Out of stock
KSh1,580.00
Out of stock
Product details
Advanced micronutrient formula to help maintain health & vitality in your 70s, 80s & beyond
With zinc which contributes to normal vision, immune & cognitive function
Expert support designed for men over 70. Wellman® 70+ has been developed to help maintain health in men aged 70 & above. With specialist bio-active nutrients to support age-related areas of health including:
Male Health & Immune System: The comprehensive formula includes zinc which helps to maintain normal testosterone levels in the blood, plus vitamins D, B6 & B12 which contribute to the normal function of the immune system.
Normal Vision: Wellman® 70+ contains vitamins C and E which contribute to the protection of cells from oxidative stress, and zinc which helps to maintain normal vision.
Cognitive Function: With iron, iodine and zinc which contribute to normal cognitive function while pantothenic acid contributes to normal mental performance. Plus vitamins B6, B12 and C which contribute to the normal functioning of the nervous system.
The UK Department of Health Advises: Adults aged 65 and over should take a supplement containing vitamin D. Wellman® 70+ provides effective levels of vitamin D, in the preferred D3 form.
No salt or yeast
Gluten free
No preservatives or artificial colours
Wellman® 70+ is not tested on animals
Suitable for vegetarians
How to use
One tablet per day with your main meal.
Swallow with water or a cold drink.
Not to be chewed. Do not exceed the recommended intake. To be taken on a full stomach.
This comprehensive formula replaces other Wellman® supplements and multivitamins. There is no need to take an additional multivitamin.
Store below 25°C in a dry place, out of sight and reach of children.
Hazards and Cautions
As with other food supplements, seek professional advice before using if you are under medical supervision or suffer from food allergies.
Based on 0 reviews
Be the first to review “Wellman 70+Tablets 30`S”
You must be logged in to post a review.
There are no reviews yet.